Business & Economics Books:

Exclusivity and Drug R&d in the Us

Format

Paperback

Customer rating

Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Share this product

Exclusivity and Drug R&d in the Us by Sreedevi Gummuluri
Save $86.00
$131.99 was $217.99
or 4 payments of $33.00 with Learn more
In stock with supplier

The item is brand new and in-stock in with one of our preferred suppliers. The item will ship from the Mighty Ape warehouse within the timeframe shown below.

Usually ships within 2-3 weeks

Availability

Delivering to:

Estimated arrival:

  • Around 28 Jan to 1 Feb using Express Delivery
    Mighty Ape can deliver this product within 1-2 business days (usually overnight) to urban centres across Australia, and some remote areas. Learn more
    Unlikely to arrive before Christmas
  • Around 29 Jan to 5 Feb using standard courier delivery
    Unlikely to arrive before Christmas

Description

This book explores the effect of marginal changes in the exclusivity environment, on research efforts of firms involved in drug R&D and production in the US. Exclusivity here refers to the IP environment and marketing regulations of the Food and Drug Administration (FDA), both of which determine the exclusive marketing period and appropriation allowed for drug research. In the US, drugs have to go through a long approval process with the FDA before marketing. Several legal decisions were instrumental in recognizing weak links in this process over 1984 to 2003 when key statutory amendments were passed. This book starts by providing some background on the IP and drug regulation in the US. Next, using the event study method, the reaction of firms categorized into three groups- Pharmaceuticals, Biotechs and Generics are analyzed as a consequence of some precedent-setting patent and regulatory cases. Cases returning significant abnormal returns are then considered in further analyzing the research behavior of pharmaceutical and biotech firms. This book is addressed to anyone interested in the drug research appropriation debates in the US including patent law and public policy experts.
Release date Australia
February 28th, 2008
Country of Publication
Germany
Illustrations
black & white illustrations
Imprint
VDM Verlag Dr. Mueller E.K.
Dimensions
170x244x9
ISBN-13
9783836436373
Product ID
2407373

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Help & options

  • If you think we've made a mistake or omitted details, please send us your feedback. Send Feedback
  • If you have a question or problem with this product, visit our Help section. Get Help
  • Seen a lower price for this product elsewhere? We'll do our best to beat it. Request a better price
Filed under...